A Case of Stent Thrombosis Occurred at 5 Years after Sirolimus-Eluting Stent Implantation
10.4068/cmj.2011.47.2.124
- Author:
Su A KIM
1
;
Sang Yup LIM
Author Information
1. Department of Internal Medicine, Korea University Ansan Hospital, Ansan, Korea. vnlover@hanmail.net
- Publication Type:Case Report
- Keywords:
Drug-eluting stent;
Thrombosis;
Myocardial infarction
- MeSH:
Drug-Eluting Stents;
Myocardial Infarction;
Stents;
Thrombosis;
Ticlopidine
- From:Chonnam Medical Journal
2011;47(2):124-126
- CountryRepublic of Korea
- Language:English
-
Abstract:
Drug-eluting stents (DES) have reduced the rate of repeated revascularization of target lesions. For this reason, DES are considered to be superior to bare-metal stents in reducing the restenosis rate. However, some problems have been reported after implantation of DES. One of them, stent thrombosis, has arisen as a fatal complication. Dual antiplatelet therapy is recommended for at least 12 months after implantation of DES to prevent stent thrombosis. Here, we report a case of very late stent thrombosis that occurred 1 week after discontinuation of clopidogrel at 5 years (1832 days) after implantation of a sirolimus-eluting stent.
